A. Collado

发表

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.

F. Garrido, F. Ruiz-Cabello, T. Cabrera, 1996, Tissue antigens.

The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis

F. Garrido, A. Garcia-Lora, I. Algarra, 2008, BMC Cancer.

F. Garrido, A. Garcia-Lora, I. Algarra, 2022 .

Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.

F. Garrido, T. Cabrera, B. Tait, 2007, Tissue antigens.

High frequency of HLA-B44 allelic losses in human solid tumors.

F. Garrido, M. López-Nevot, T. Cabrera, 2003, Human immunology.

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

F. Garrido, A. Garcia-Lora, I. Algarra, 2009, Cancer Immunology, Immunotherapy.

Immunotherapy eradicates metastases with reversible defects in MHC class I expression

F. Garrido, A. Garcia-Lora, I. Algarra, 2011, Cancer Immunology, Immunotherapy.

Restoration of MHC-I on Tumor Cells by Fhit Transfection Promotes Immune Rejection and Acts as an Individualized Immunotherapeutic Vaccine

F. Garrido, A. Garcia-Lora, I. Algarra, 2020, Cancers.

Protein kinase C‐mediated regulation of the expression of CD14 and CD11 /CD18 in U937 cells

F. Garrido, F. Ruiz-Cabello, A. Collado, 1990, International journal of cancer.

Tumour immunology, vaccination and escape strategies.

F. Garrido, A. Garcia-Lora, I. Algarra, 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

Altered MHC class I antigens in tumors

F. Garrido, I. Algarra, A. Collado, 1997, International journal of clinical & laboratory research.

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

F. Garrido, L. Real, P. Jiménez, 1999, International journal of cancer.

Expression of HLA G in human tumors is not a frequent event

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 1999, International journal of cancer.

DIFFERENT PATTERNS O F HLA-DR ANTIGEN EXPRESSION

A. Concha, F. Garrido, F. Ruiz-Cabello, 2006 .

DIFFERENT PATTERNS OF HLA‐DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST

A. Concha, F. Garrido, F. Ruiz-Cabello, 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells

F. Garrido, A. Garcia-Lora, I. Algarra, 2012, The Journal of pathology.

Molecular strategies to define HLA haplotype loss in microdissected tumor cells.

F. Garrido, M. López-Nevot, T. Cabrera, 2000, Human immunology.

A monoclonal antibody GR2110 reactive with a P24 antigen present in a subgroup of acute lymphoid leukemias.

J. S. San Miguel, F. Garrido, F. Ruiz-Cabello, 1985, Hybridoma.

Characterization of CD44 antigen during lymphoid ontogeny.

F. Garrido, F. Ruiz-Cabello, A. Collado, 1991, Immunobiology.

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

F. Garrido, M. López-Nevot, C. Cabrera, 2004, Immunogenetics.

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.

F. Garrido, A. Garcia-Lora, I. Algarra, 2012, Carcinogenesis.

Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.

F. Garrido, I. Algarra, A. Collado, 1997, Journal of experimental & clinical cancer research : CR.

T lymphocytes restrain spontaneous metastases in permanent dormancy.

F. Garrido, A. Garcia-Lora, I. Algarra, 2014, Cancer research.

Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response

F. Garrido, M. López-Nevot, C. Cabrera, 2007, International journal of cancer.

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy

F. Garrido, A. Garcia-Lora, I. Algarra, 2018, Front. Immunol..

Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors.

F. Garrido, I. Algarra, A. Collado, 1999, Journal of experimental & clinical cancer research : CR.

Criteria to define HLA haplotype loss in human solid tumors.

F. Garrido, M. Tilanus, M. López-Nevot, 2000, Tissue antigens.

A new extract of the plant calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation

F. Garrido, A. Garcia-Lora, I. Algarra, 2006, BMC Cancer.